BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:58 PM
 | 
Jun 24, 2009
 |  BC Extra  |  Company News

NICE issues guidance against Erbitux in SCCHN

The U.K's NICE issued final guidance recommending against the use of Erbitux cetuximab from Merck KGaA (Xetra:MRK) in combination with platinum-based...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >